home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Precision BioSciences, Inc. - Common Stock (NQ:DTIL)

4.710 +0.100 (+2.17%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Precision BioSciences, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Precision BioSciences to Participate in Upcoming H.C. Wainwright Cell Therapy Virtual Conference

February 22, 2023

From Precision BioSciences, Inc.

Via Business Wire

There's a Lot of Upside For Emerging Gene-Editing Companies

February 21, 2023

These four gene-editing companies are brand new, with very high upside potential. The industry itself is still emerging, which means more growth could come.

Via MarketBeat

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

February 14, 2023

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Earnings Perspective: Return On Capital Employed ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 06, 2023

Via Benzinga

Precision BioSciences Recaps 2022 Accomplishments and Outlines 2023 Corporate Priorities and Planned Portfolio Milestones

January 09, 2023

From Precision BioSciences

Via Business Wire

Precision BioSciences Receives Favorable Type C Feedback from the FDA on the Company’s Chemistry, Manufacturing, and Controls (CMC) Strategies for Late-Stage Development of Azercabtagene Zapreleucel, its Lead Allogeneic CAR T Clinical Candidate

January 06, 2023

From Precision BioSciences, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Precision BioSciences Presents Analysis of Azer-Cel, Allogeneic CAR T Product Attributes Related to In Vivo Pharmacokinetics, Pharmacodynamics, and Clinical Outcomes at 2022 American Society of Hematology Annual Meeting

December 10, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Change to its Board of Directors

November 10, 2022

From Precision BioSciences, Inc.

Via Business Wire

Coinbase To $80? Plus Deutsche Bank Cuts PT On This Stock By 80% ↗

November 10, 2022

Citigroup cut the price target on Coinbase Global, Inc. (NASDAQ: COIN) from $105 to $80. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Coinbase shares rose 2.1% to $46.95...

Via Benzinga

Precision BioSciences Reports Third Quarter 2022 Financial Results and Provides Business Update

November 08, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences's Earnings Outlook ↗

November 07, 2022

Precision BioSciences (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

November 04, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Data Presentation on Effective Cell Dose and Functional Attributes of CD19 Allogeneic CAR T, Azer-Cel, at the Upcoming 2022 American Society of Hematology (ASH) Annual Meeting

November 03, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022

November 02, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4)

October 26, 2022

From Precision BioSciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 29th Congress

October 11, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Participate in Upcoming Jefferies Cell & Genetic Medicine Summit

September 22, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference

September 07, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Senior Leadership Organizational Changes

September 02, 2022

From Precision BioSciences, Inc.

Via Business Wire

Looking Into Precision BioSciences, Inc. - Common Stock's Return On Capital Employed ↗

August 30, 2022

Benzinga Pro data, Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) reported Q2 sales of $3.82 million. Earnings fell to a loss of $31.04 million, resulting in a 10.18% decrease from last...

Via Benzinga

Precision BioSciences: Q2 Earnings Insights ↗

August 08, 2022

Precision BioSciences (NASDAQ:DTIL) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Precision BioSciences Reports Second Quarter 2022 Financial Results and Provides Business Update

August 08, 2022

From Precision BioSciences, Inc.

Via Business Wire

Earnings Preview: Precision BioSciences, Inc. - Common Stock ↗

August 05, 2022

Precision BioSciences, Inc. - Common Stock (NASDAQ:DTIL) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement.

Via Benzinga

Precision BioSciences to Report Second Quarter 2022 Financial Results on August 8, 2022

August 01, 2022

From Precision BioSciences, Inc.

Via Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

July 25, 2022

From Precision BioSciences, Inc.

Via Business Wire

Global Pancreatic Cancer Therapeutics & Diagnostics Market Expected To Reach $5.6 Billion By 2027

June 28, 2022

Palm Beach, FL – June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent...

Via FinancialNewsMedia

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com